Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam

Saved in:
Bibliographic Details
Published in:European journal of clinical pharmacology Vol. 64; no. 1; pp. 93 - 94
Main Authors: Tóth, Mária, Drabant, Sándor, Varga, Bálint, Végső, Gyula, Cseh, Anna, Szentpéteri, Imre, Klebovich, Imre
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer-Verlag 2008
Springer Nature B.V
Subjects:
Adjuvants, Anesthesia - pharmacokinetics
Antidepressive Agents - pharmacology
Area Under Curve
Benzodiazepines - pharmacology
Biomedical and Life Sciences
Biomedicine
Cytochrome P-450 CYP3A - drug effects
Cytochrome P-450 CYP3A - metabolism
Drug Interactions
Half-Life
Humans
Intestinal Mucosa - metabolism
Intestines - drug effects
Letter to the Editors
Liver - drug effects
Liver - metabolism
Male
Midazolam - pharmacokinetics
Pharmacology/Toxicology
Alprazolam
Intestinal Level
Midazolam
Tacrolimus
Digit Symbol Substitution Test
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0031-6970
1432-1041
DOI:10.1007/s00228-007-0397-y